Cargando…
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study
BACKGROUND: Dupilumab has shown long-term treatment benefits in children with uncontrolled asthma. We assessed in more detail the impact of dupilumab on asthma control and health-related quality of life (HRQoL) in children and their caregivers. METHODS: Children aged 6–11 years with uncontrolled mod...
Autores principales: | Fiocchi, Alessandro G., Phipatanakul, Wanda, Zeiger, Robert S., Durrani, Sandy R., Cole, Jeremy, Msihid, Jérôme, Gall, Rebecca, Jacob-Nara, Juby A., Deniz, Yamo, Rowe, Paul J., Lederer, David J., Hardin, Megan, Zhang, Yi, Khan, Asif H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620476/ https://www.ncbi.nlm.nih.gov/pubmed/37734856 http://dx.doi.org/10.1183/13993003.00558-2023 |
Ejemplares similares
-
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
por: Hopkins, Claire, et al.
Publicado: (2022) -
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
por: Busse, William Walter, et al.
Publicado: (2023) -
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
por: Domingo, Christian, et al.
Publicado: (2023) -
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
por: Bachert, Claus, et al.
Publicado: (2022) -
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
por: Hellings, Peter W., et al.
Publicado: (2022)